Published in BMC Cancer on June 30, 2008
Molecular functions of syndecan-1 in disease. Matrix Biol (2011) 1.47
The tumor microenvironment in colorectal carcinogenesis. Cancer Microenviron (2010) 1.23
Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: a systematic review and meta-analysis. BMC Med (2013) 1.09
Syndecan-1-dependent suppression of PDK1/Akt/bad signaling by docosahexaenoic acid induces apoptosis in prostate cancer. Neoplasia (2010) 1.02
Sdc1 negatively modulates carcinoma cell motility and invasion. Exp Cell Res (2009) 0.91
Fascin expression in colorectal carcinomas. Clinics (Sao Paulo) (2010) 0.88
Syndecan-1 expression is associated with tumor size and EGFR expression in colorectal carcinoma: a clinicopathological study of 230 cases. Int J Med Sci (2015) 0.86
The effect of proteoglycans inhibited by RNA interference on metastatic characters of human salivary adenoid cystic carcinoma. BMC Cancer (2009) 0.85
Shed Syndecan-1 is involved in chemotherapy resistance via the EGFR pathway in colorectal cancer. Br J Cancer (2014) 0.84
Chronic cyclooxygenase-2 inhibition promotes myofibroblast-associated intestinal fibrosis. Cancer Prev Res (Phila) (2010) 0.83
Carbohydrate-containing molecules as potential biomarkers in colon cancer. OMICS (2014) 0.81
Syndecan-1 in Cancer: Implications for Cell Signaling, Differentiation, and Prognostication. Dis Markers (2015) 0.80
Prognostic and clinical significance of syndecan-1 in colorectal cancer: a meta-analysis. BMC Gastroenterol (2015) 0.76
Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine. Oncotarget (2015) 0.76
Syndecans as Cell Surface Receptors in Cancer Biology. A Focus on their Interaction with PDZ Domain Proteins. Front Pharmacol (2016) 0.75
Heparan sulfate proteoglycans undergo differential expression alterations in right sided colorectal cancer, depending on their metastatic character. BMC Cancer (2015) 0.75
Endothelial Glycocalyx as Biomarker for Cardiovascular Diseases: Mechanistic and Clinical Implications. Curr Heart Fail Rep (2017) 0.75
Syndecan-1 deficiency promotes tumor growth in a murine model of colitis-induced colon carcinoma. PLoS One (2017) 0.75
Syndecan-1-Induced ECM Fiber Alignment Requires Integrin αvβ3 and Syndecan-1 Ectodomain and Heparan Sulfate Chains. PLoS One (2016) 0.75
Tumor stroma and regulation of cancer development. Annu Rev Pathol (2006) 6.66
Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol (1992) 4.37
Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res (2007) 2.26
Syndecans in wound healing, inflammation and vascular biology. Int J Biochem Cell Biol (2006) 2.05
Different mechanisms in the tumorigenesis of proximal and distal colon cancers. Curr Opin Oncol (2001) 1.74
Defects in keratinocyte activation during wound healing in the syndecan-1-deficient mouse. J Cell Sci (2002) 1.72
Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas. BMC Cancer (2006) 1.62
Endogenous attenuation of allergic lung inflammation by syndecan-1. J Immunol (2005) 1.38
Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers. Int J Cancer (2000) 1.37
Expression of syndecan-1 inhibits cell invasion into type I collagen. J Biol Chem (1994) 1.34
Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells. Proc Natl Acad Sci U S A (1992) 1.29
Syndecan-1: a dynamic regulator of the myeloma microenvironment. Clin Exp Metastasis (2007) 1.27
Mammary gland development requires syndecan-1 to create a beta-catenin/TCF-responsive mammary epithelial subpopulation. Oncogene (2003) 1.25
Reduced migration, altered matrix and enhanced TGFbeta1 signaling are signatures of mouse keratinocytes lacking Sdc1. J Cell Sci (2007) 1.17
Prognostic value of syndecan-1 expression in breast cancer. Oncology (2004) 1.16
Reduced expression of syndecan-1 affects metastatic potential and clinical outcome in patients with colorectal cancer. Jpn J Cancer Res (2001) 1.16
Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development. Oncogene (2006) 1.15
A role for syndecan-1 in coupling fascin spike formation by thrombospondin-1. J Cell Biol (2001) 1.15
Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck. Br J Cancer (1994) 1.12
Migratory marker expression in fibroblast foci of idiopathic pulmonary fibrosis. Respir Res (2006) 1.10
Shift of syndecan-1 expression from epithelial to stromal cells during progression of solid tumours. Eur J Cancer (2004) 1.09
Comparative genomics of the syndecans defines an ancestral genomic context associated with matrilins in vertebrates. BMC Genomics (2006) 1.07
Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer. Int J Cancer (2001) 1.05
Independent prognostic value of fascin immunoreactivity in stage III-IV colonic adenocarcinoma. Br J Cancer (2007) 1.04
Epithelial syndecan-1 expression is associated with stage and grade in colorectal cancer. Oncology (2005) 1.03
Steroid-induced epithelial-fibroblastic conversion associated with syndecan suppression in S115 mouse mammary tumor cells. Cell Regul (1991) 0.98
Functional role of syndecan-1 cytoplasmic V region in lamellipodial spreading, actin bundling, and cell migration. Mol Biol Cell (2005) 0.97
Syndecan-1 expression in mammary epithelial tumor cells is E-cadherin-dependent. J Cell Sci (1996) 0.96
Changes in the expression of syndecan-1 in the colorectal adenoma-carcinoma sequence. Virchows Arch (1999) 0.95
Loss of cell-surface heparan sulfate expression in both cervical intraepithelial neoplasm and invasive cervical cancer. Gynecol Oncol (2005) 0.93
Prognostic significance of syndecan-1 expression in human endometrial cancer. Ann Oncol (2005) 0.88
Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components. J Exp Clin Cancer Res (2004) 0.88
Stromal syndecan-1 expression is an adverse prognostic factor in oral carcinomas. Oral Oncol (2005) 0.85
Syndecan-1 alterations during the tumorigenic progression of human colonic Caco-2 cells induced by human Ha-ras or polyoma middle T oncogenes. Br J Cancer (1996) 0.84
A prognostic value of syndecan-1 in gastric cancer. Anticancer Res (2001) 0.83
Predictive value of syndecan-1 expression for the response to neoadjuvant chemotherapy of primary breast cancer. Anticancer Res (2006) 0.83
Directional control of lamellipodia extension by constraining cell shape and orienting cell tractional forces. FASEB J (2002) 3.45
Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker? Int J Biochem Cell Biol (2005) 2.39
Molecular phylogeny of the kelch-repeat superfamily reveals an expansion of BTB/kelch proteins in animals. BMC Bioinformatics (2003) 2.10
Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms. Mod Pathol (2008) 1.95
Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. Am J Pathol (2003) 1.80
The expression of fascin, an actin-bundling motility protein, correlates with hormone receptor-negative breast cancer and a more aggressive clinical course. Clin Cancer Res (2005) 1.68
Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas. BMC Cancer (2006) 1.62
Structure of a thrombospondin C-terminal fragment reveals a novel calcium core in the type 3 repeats. EMBO J (2004) 1.62
Laparoscopic anatrophic nephrolithotomy: feasibility study in a chronic porcine model. J Urol (2003) 1.58
Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies. Am J Gastroenterol (2008) 1.46
Dual actin-bundling and protein kinase C-binding activities of fascin regulate carcinoma cell migration downstream of Rac and contribute to metastasis. Mol Biol Cell (2007) 1.45
Interaction of fascin and protein kinase Calpha: a novel intersection in cell adhesion and motility. EMBO J (2003) 1.45
BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis. Dis Colon Rectum (2012) 1.42
The evolution of extracellular matrix. Mol Biol Cell (2010) 1.40
Prostate cancer in African American men is associated with downregulation of zinc transporters. Appl Immunohistochem Mol Morphol (2003) 1.37
Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings. Am J Clin Pathol (2007) 1.36
The roles of fascins in health and disease. J Pathol (2011) 1.35
Dual-color, break-apart fluorescence in situ hybridization for EWS gene rearrangement distinguishes clear cell sarcoma of soft tissue from malignant melanoma. Mod Pathol (2005) 1.19
Development of a clinically feasible molecular assay to predict recurrence of stage II colon cancer. J Mol Diagn (2008) 1.17
Novel role of the muskelin-RanBP9 complex as a nucleocytoplasmic mediator of cell morphology regulation. J Cell Biol (2008) 1.15
Expression of fascin-1, the gene encoding the actin-bundling protein fascin-1, during mouse embryogenesis. Gene Expr Patterns (2004) 1.14
The evolution of thrombospondins and their ligand-binding activities. Mol Biol Evol (2010) 1.12
Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: a systematic review and meta-analysis. BMC Med (2013) 1.09
Comparative genomics of the syndecans defines an ancestral genomic context associated with matrilins in vertebrates. BMC Genomics (2006) 1.07
The influence of polysomy 17 on HER2 gene and protein expression in adenocarcinoma of the breast: a fluorescent in situ hybridization, immunohistochemical, and isotopic mRNA in situ hybridization study. Am J Surg Pathol (2005) 1.05
Prediction and analysis of higher-order coiled-coils: insights from proteins of the extracellular matrix, tenascins and thrombospondins. Int J Biochem Cell Biol (2013) 1.03
Fascin-1 promoter activity is regulated by CREB and the aryl hydrocarbon receptor in human carcinoma cells. PLoS One (2009) 1.01
Trimeric assembly of the C-terminal region of thrombospondin-1 or thrombospondin-2 is necessary for cell spreading and fascin spike organisation. J Cell Sci (2002) 1.01
Rac regulates the interaction of fascin with protein kinase C in cell migration. J Cell Sci (2008) 1.01
Eccrine angiomatous hamartoma in a neurofibromatosis type-1 patient. Pathology (2002) 1.01
Chromosomal gains and genomic loss of p53 and p16 genes in Barrett's esophagus detected by fluorescence in situ hybridization of cytology specimens. Mod Pathol (2004) 1.00
Transfer and multiplex immunoblotting of a paraffin embedded tissue. Proteomics (2006) 0.98
Functional role of syndecan-1 cytoplasmic V region in lamellipodial spreading, actin bundling, and cell migration. Mol Biol Cell (2005) 0.97
Primary extraosseous ewing sarcoma of the kidney with level III inferior vena cava thrombus. Clin Genitourin Cancer (2009) 0.96
Neuronal expression of muskelin in the rodent central nervous system. BMC Neurosci (2007) 0.96
Identifying Lynch syndrome: we are all responsible. Dis Colon Rectum (2008) 0.95
Adhesion-modulating/matricellular ECM protein families: a structural, functional and evolutionary appraisal. Matrix Biol (2012) 0.95
A novel Rho-dependent pathway that drives interaction of fascin-1 with p-Lin-11/Isl-1/Mec-3 kinase (LIMK) 1/2 to promote fascin-1/actin binding and filopodia stability. BMC Biol (2012) 0.94
Coronary artery disease and the thrombospondin single nucleotide polymorphisms. Int J Biochem Cell Biol (2004) 0.94
Analytical validation and interobserver reproducibility of EnzMet GenePro: a second-generation bright-field metallography assay for concomitant detection of HER2 gene status and protein expression in invasive carcinoma of the breast. Am J Surg Pathol (2005) 0.93
Induction of fascin spikes in breast cancer cells by activation of the insulin-like growth factor-I receptor. Int J Biochem Cell Biol (2002) 0.92
Regulation of post-translational modifications of muskelin by protein kinase C. Int J Biochem Cell Biol (2006) 0.91
Functional role of alpha-actinin, PI 3-kinase and MEK1/2 in insulin-like growth factor I receptor kinase regulated motility of human breast carcinoma cells. J Cell Sci (2002) 0.91
Statin therapy is associated with improved pathologic response to neoadjuvant chemoradiation in rectal cancer. Dis Colon Rectum (2013) 0.91
Molecular phylogeny of a RING E3 ubiquitin ligase, conserved in eukaryotic cells and dominated by homologous components, the muskelin/RanBPM/CTLH complex. PLoS One (2013) 0.91
Fluorescence in situ hybridization of cytologic specimens from Barrett's esophagus: a pilot feasibility study. Gastrointest Endosc (2004) 0.89
The utility of fluorescence in situ hybridization (FISH) in the diagnosis of myxoid soft tissue neoplasms. Am J Surg Pathol (2008) 0.88
Phylogenomic analysis of vertebrate thrombospondins reveals fish-specific paralogues, ancestral gene relationships and a tetrapod innovation. BMC Evol Biol (2006) 0.87
MAL is expressed in a subset of Hodgkin lymphoma and identifies a population of patients with poor prognosis. Am J Clin Pathol (2006) 0.87
Gold-facilitated in situ hybridization: a bright-field autometallographic alternative to fluorescence in situ hybridization for detection of Her-2/neu gene amplification. Am J Pathol (2002) 0.87
Effect of intentional cryo-injury to the renal collecting system. J Urol (2003) 0.87
Microarray gene expression profiling and analysis in renal cell carcinoma. BMC Urol (2004) 0.86
Molecular analysis of muskelin identifies a conserved discoidin-like domain that contributes to protein self-association. Biochem J (2004) 0.86
The specificity of interphase FISH translocation probes in formalin fixed paraffin embedded tissue sections is readily assessed using automated staining and scoring of tissue microarrays constructed from murine xenografts. J Mol Histol (2006) 0.86
Epithelioid sarcoma: an immunohistochemical analysis evaluating the utility of cytokeratin 5/6 in distinguishing superficial epithelioid sarcoma from spindled squamous cell carcinoma. J Cutan Pathol (2003) 0.86
Novel bright field molecular morphology methods for detection of HER2 gene amplification. J Mol Histol (2004) 0.84
Primary intravascular synovial sarcoma: a disease of young adult women? Report of a case diagnosed by aspiration biopsy and review of the literature. Diagn Cytopathol (2006) 0.82
Prediction of adenocarcinoma in esophagectomy specimens based upon analysis of preresection biopsies of Barrett esophagus with at least high-grade dysplasia: a comparison of 2 systems. Am J Surg Pathol (2012) 0.81
Familial colorectal cancer type X: polyp burden and cancer risk stratification via a family history score. ANZ J Surg (2012) 0.80
The utility of FOXO1 fluorescence in situ hybridization (FISH) in formalin-fixed paraffin-embedded specimens in the diagnosis of alveolar rhabdomyosarcoma. Diagn Mol Pathol (2009) 0.79
Interobserver interpretative reproducibility of GOLDFISH, a first generation gold-facilitated autometallographic bright field in situ hybridization assay for HER-2/neu amplification in invasive mammary carcinoma. Am J Surg Pathol (2002) 0.79
Array-based comparative genomic hybridization in ulcerative colitis neoplasia: single non-dysplastic biopsies distinguish progressors from non-progressors. Mod Pathol (2010) 0.78
Laparoscopic ureterocalicostomy: a feasibility study. J Urol (2003) 0.78
A thrombospondin in the anthozoan Nematostella vectensis is associated with the nervous system and upregulated during regeneration. Biol Open (2012) 0.77
Nuclear, intradiscal hemangioma. Pain Pract (2008) 0.75
Molecular and cellular evolution: a celebration of the 200th anniversary of the birth of Charles Darwin. Int J Biochem Cell Biol (2008) 0.75